Actos Recall (100% LIMITED)

: The FDA requires a "black box" warning—its strongest level—on the product label to alert patients to the risk of congestive heart failure . Major Legal Settlements

: In June 2011, the FDA issued a safety communication warning that using Actos for more than one year may increase the risk of bladder cancer by 40%. ACTOS RECALL

: Following a 2011 French study linking the drug to bladder cancer, medical authorities in France and Germany suspended or banned the use of Actos. : The FDA requires a "black box" warning—its

Takeda Pharmaceuticals , the manufacturer, has faced thousands of lawsuits from patients alleging they were not properly warned about the risk of bladder cancer. Actos Recall in the U.S. | Girard Gibbs LLP Key Safety Warnings and Bans While there have

However, the drug has faced bans in other countries and intense legal scrutiny due to serious health concerns. Key Safety Warnings and Bans

While there have been significant legal and international developments, it is important to clarify that .